Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
OTC Drugs

CHPA board and chair

This article was originally published in The Tan Sheet

  • News

Executive Summary

Lil' Drug Store Products President and CEO Christopher DeWolf takes the helm of the Consumer Healthcare Products Association's board. DeWolf succeeds John Hendrickson of Perrigo as chairman, CHPA announces March 14 during its executive conference in Naples, Fla. Joining DeWolf on the board are vice chairmen Timothy Brown, Procter & Gamble's North American Personal Health general manager; Patrick Lonergan, president of NUMARK Laboratories; James Mackey, senior VP of sales and operations of consumer healthcare at Schering-Plough Health Care Products; Jeffrey Needham, senior VP commercial business development with Perrigo; and Cavan Redmond, president of Wyeth Consumer Healthcare

Table

View full table

Topics

Tags:
OTC Drugs
Latest Headlines

Cancer Trials: FDA Wants Lower Performance Status Eligibility But Primary Analysis Exclusion OK

US FDA's Califf Defends Agency Work On Marijuana Rescheduling, Animal Testing

Overall Survival Is Not A Required Primary Endpoint In All Cancer Trials, US FDA Says

Australia Calls For Companion Testing Plans For Drugs Requiring A CDx

See All
UsernamePublicRestriction

Register

PS102700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By